Fda Issues Safety Alert Over Sglt2inhibitors | Latest News RSS feed

Fda Issues Safety Alert Over Sglt2inhibitors - Latest News


FDA issues safety alert over MS drug Gilenya

A patient who was taking the multiple sclerosis drug Gilenya, manufactured by Novartis, developed a rare brain infection, according to safety alert by the FDA. The alert stated that this is the first ... read more

Clinical Decision Support Systems (CDSS) Market To Grow with Healthy CAGR 2028

The on-premise delivery mode segment is expected to register highest share over the forecast ... and information safety issues. On the basis of application, the target market is segmented into drug-dr... read more

Letter from The Editor: The oxymoron that FDA keeps alive

FDA officials outlined the new mandatory recall policy this past November. The FDA, which has jurisdiction over about 80 percent of food in ... providing more information on recalls and other safety i... read more

Looking for another news?


FDA Tightening Oversight of Dietary Supplement Industry

... stated an intent to step up FDA efforts to improve product safety and police deceptive claims. Amongst other initiatives, Mr. Gottlieb stated that the Agency is developing a new “rapid response to... read more


Food inspections by the FDA have been sharply reduced, alarming critics

The furloughing of hundreds of Food and Drug Administration inspectors has sharply reduced ... As the shutdown continues, questions about safety and security issues are drawing more attention. On Tues... read more

FDA commissioner announces plan to modernize regulation of dietary supplements

“We’re developing a new rapid-response tool to alert the public ... supplements before they are placed on the market. Over the years, FDA has objected to the majority of NDI notifications due to safet... read more

Eli Lilly Gets Another Crack At FDA Approval For RA Drug

Eli Lilly gets allowance from the FDA to file for regulatory approval of its JAK inhibitor drug baricitinib for patients with rheumatoid arthritis. A setback by the FDA on safety issues caused baricit... read more

You Definitely Used One of These Deadly Household Items Today

Flea and Tick Products.Pet's flea and tick products may save your pooch from unwanted bites but due to pesticides it can lead to nerve damage, neurological problems, seizures, and more according to an ... read more

Expert Consensus Decision Pathway Addresses Changing Paradigm in Managing T2D Patients With ASCVD

"Specifically, potential side effects, drug-drug interactions, and safety issues should be explained clearly, patient preference and other concerns elicited, and cost discussed, since SGLT2 inhibitors ... read more

Recalls Have 60% of Pet Parents Concerned About the Safety of Dog and Cat Food, reports Packaged Facts

Feb. 6, 2019 /PRNewswire/ -- Hill's Pet Nutrition's recent recall is a reminder that safety remains one ... In December 2018, the FDA issued an alert to pet owners about food from eight different ... read more

79 Percent of Healthcare Leaders See ROI in Clinical Surveillance; Four in Five Say it Definitely Improves Quality Measures

Respondents identified the top five ways clinical surveillance can be most helpful today as: (No. 1) identifying adverse drug events, (No. 2) advancing antimicrobial stewardship initiatives, (No. 3) p... read more

GlaxoSmithKline Catches Multiple Safety Nets From FDA For Blockbuster Drug Advair

GlaxoSmithKline received a second lifeline after the FDA rejected Mylan (MYL) generic version of Advair for a second time. Mylan had stated that the FDA could not approve the drug. The FDA stated that ... read more



FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us